In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines

In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines

Hasaya Dokduang,1,2 Wassana Jamnongkarn,1,2 Bundit Promraksa,2,3 Manida Suksawat,3 Sureerat Padthaisong,2,3 Malinee Thanee,1,2 Jutarop Phetcharaburanin,1– 3 Nisana Namwat,1– 3 Sakkarn Sangkhamanon,2,4 Attapol Titapun,1,2,5 Narong Khuntikeo,1,2,5 Poramate Klanrit,1– 3 Wa...

Full description

Bibliographic Details
Main Authors: Dokduang H, Jamnongkarn W, Promraksa B, Suksawat M, Padthaisong S, Thanee M, Phetcharaburanin J, Namwat N, Sangkhamanon S, Titapun A, Khuntikeo N, Klanrit P, Loilome W
Format: Article
Language:English
Published: Dove Medical Press 2020-06-01
Series:Drug Design, Development and Therapy
Subjects:
cholangiocarcinoma
varlitinib
pan her inhibitor
her receptor family
Online Access:https://www.dovepress.com/in-vitro-and-in-vivo-anti-tumor-effects-of-pan-her-inhibitor-varlitini-peer-reviewed-article-DDDT

Similar Items

Similar Items